UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5694) 5694
Newsletter (183) 183
Newspaper Article (36) 36
Book Chapter (31) 31
Publication (16) 16
Dissertation (12) 12
Conference Proceeding (9) 9
Magazine Article (8) 8
Web Resource (3) 3
Book Review (1) 1
Paper (1) 1
Reference (1) 1
Streaming Video (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
capecitabine (5243) 5243
humans (4328) 4328
science & technology (3684) 3684
life sciences & biomedicine (3599) 3599
deoxycytidine - analogs & derivatives (3247) 3247
female (3081) 3081
fluorouracil - analogs & derivatives (2965) 2965
oncology (2833) 2833
middle aged (2585) 2585
aged (2421) 2421
male (2247) 2247
deoxycytidine - administration & dosage (2185) 2185
antineoplastic combined chemotherapy protocols - therapeutic use (2174) 2174
fluorouracil - administration & dosage (1996) 1996
adult (1891) 1891
chemotherapy (1613) 1613
cancer (1428) 1428
treatment outcome (1421) 1421
biological and medical sciences (1096) 1096
medical sciences (1094) 1094
deoxycytidine - adverse effects (1089) 1089
deoxycytidine - therapeutic use (1047) 1047
tumors (1042) 1042
antineoplastic combined chemotherapy protocols - adverse effects (980) 980
breast neoplasms - drug therapy (974) 974
fluorouracil - adverse effects (915) 915
care and treatment (904) 904
colorectal cancer (896) 896
fluorouracil - therapeutic use (878) 878
colorectal neoplasms - drug therapy (846) 846
antineoplastic agents (838) 838
aged, 80 and over (830) 830
breast cancer (782) 782
organoplatinum compounds - administration & dosage (769) 769
research (758) 758
antimetabolites, antineoplastic - therapeutic use (752) 752
disease-free survival (723) 723
metastasis (708) 708
neoplasm staging (697) 697
pharmacology & pharmacy (628) 628
oxaliplatin (627) 627
capecitabine - administration & dosage (614) 614
pharmacology. drug treatments (611) 611
antimetabolites, antineoplastic - adverse effects (593) 593
breast neoplasms - pathology (589) 589
antineoplastic combined chemotherapy protocols - administration & dosage (564) 564
medicine & public health (560) 560
neoplasm metastasis (559) 559
antimetabolites, antineoplastic - administration & dosage (535) 535
drug administration schedule (529) 529
retrospective studies (507) 507
drug therapy (496) 496
adenocarcinoma - drug therapy (488) 488
survival rate (472) 472
prognosis (462) 462
bevacizumab (458) 458
colorectal neoplasms - pathology (456) 456
gastroenterology. liver. pancreas. abdomen (451) 451
hematology, oncology and palliative medicine (448) 448
administration, oral (447) 447
clinical trials (443) 443
antineoplastic agents - therapeutic use (439) 439
chemotherapy, adjuvant (425) 425
stomach neoplasms - drug therapy (408) 408
camptothecin - analogs & derivatives (404) 404
survival analysis (383) 383
analysis (379) 379
oncology, experimental (372) 372
antimitotic agents (371) 371
health aspects (370) 370
follow-up studies (350) 350
stomach. duodenum. small intestine. colon. rectum. anus (349) 349
patients (346) 346
surgery (345) 345
5-fluorouracil (344) 344
combined modality therapy (338) 338
toxicity (331) 331
radiotherapy (324) 324
camptothecin - administration & dosage (318) 318
taxoids - administration & dosage (315) 315
cancer research (314) 314
prospective studies (311) 311
cisplatin - administration & dosage (304) 304
cancer therapies (301) 301
dosage and administration (301) 301
dose-response relationship, drug (301) 301
leucovorin - administration & dosage (300) 300
cancer patients (298) 298
capecitabine - therapeutic use (295) 295
disease progression (294) 294
capecitabine - adverse effects (292) 292
neoadjuvant therapy (291) 291
fluorouracil (290) 290
adenocarcinoma - pathology (289) 289
kaplan-meier estimate (280) 280
rectal neoplasms - pathology (272) 272
antibodies, monoclonal, humanized (268) 268
irinotecan (268) 268
liver neoplasms - secondary (267) 267
pharmacology/toxicology (264) 264
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5600) 5600
Japanese (200) 200
Chinese (75) 75
French (61) 61
German (55) 55
Russian (43) 43
Spanish (30) 30
Korean (21) 21
Italian (19) 19
Dutch (15) 15
Portuguese (12) 12
Turkish (11) 11
Czech (10) 10
Hungarian (7) 7
Polish (7) 7
Danish (4) 4
Norwegian (2) 2
Romanian (2) 2
Arabic (1) 1
Finnish (1) 1
Hebrew (1) 1
Lithuanian (1) 1
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of translational medicine, ISSN 1479-5876, 05/2016, Volume 14, Issue 1, pp. 125 - 125
Journal Article
Annals of oncology, ISSN 0923-7534, 06/2018, Volume 29, pp. v90 - v90
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2020, Volume 382, Issue 7, pp. 597 - 609
Journal Article
Annals of oncology, ISSN 0923-7534, 09/2017, Volume 28, pp. v151 - v151
Journal Article
Revue neurologique, ISSN 0035-3787, 09/2020, Volume 176, pp. S139 - S139
Journal Article
Clinical breast cancer, ISSN 1526-8209, 08/2018, Volume 18, Issue 4, pp. 289 - 297
Buparlisib | Breast cancer | Phase I | PI3K | Capecitabine | Life Sciences & Biomedicine | Oncology | Science & Technology | Capecitabine - administration & dosage | Breast Neoplasms - secondary | Phosphoinositide-3 Kinase Inhibitors | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Antimetabolites, Antineoplastic - pharmacokinetics | Humans | Middle Aged | Aminopyridines - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Aminopyridines - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Protein Kinase Inhibitors - adverse effects | Antimetabolites, Antineoplastic - administration & dosage | Dose-Response Relationship, Drug | Adult | Female | Morpholines - adverse effects | Capecitabine - pharmacokinetics | Protein Kinase Inhibitors - pharmacokinetics | Aminopyridines - administration & dosage | Aminopyridines - toxicity | Drug Administration Schedule | Morpholines - administration & dosage | Capecitabine - toxicity | Treatment Outcome | Breast Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - toxicity | Phosphatidylinositol 3-Kinases - genetics | Protein Kinase Inhibitors - administration & dosage | Maximum Tolerated Dose | Capecitabine - adverse effects | Antimetabolites, Antineoplastic - adverse effects | Antimetabolites, Antineoplastic - toxicity | Protein Kinase Inhibitors - toxicity | Morpholines - toxicity | Morpholines - pharmacokinetics | Mutation | Complications and side effects | Enzyme inhibitors | Patient outcomes | Metastasis | Drug therapy | Index Medicus
Journal Article
EJNMMI research, ISSN 2191-219X, 2019, Volume 9, Issue 1, p. 13
Journal Article
Journal Article